Blockade of Tissue Factor
- 1 May 2003
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 167 (9) , 1200-1209
- https://doi.org/10.1164/rccm.200204-287oc
Abstract
Blockade of tissue factor before lethal sepsis prevents acute lung injury and renal failure in baboons, indicating that activation of coagulation by tissue factor is an early event in the pathogenesis of acute lung injury and organ dysfunction. We hypothesized that blockade of tissue factor would also attenuate these injuries in established sepsis by prevention of further fibrin deposition and inflammation. Twelve male baboons received heat-killed Escherichia coli intravenously followed 12 hours later by live E. coli infusion. Six animals were treated 2 hours after the live bacteria with site-inactivated Factor VIIa, a competitive tissue factor inhibitor, and six animals were vehicle-treated sepsis control subjects. Animals were ventilated and monitored for 48 hours. Physiologic and hematologic parameters were measured every 6 hours, and pathologic evaluation was performed after 48 hours. Animals treated with site inactivated Factor VIIa had less severe lung injury, with preserved gas exchange, better lung compliance and histology scores, and decreased lung wet/dry weight. In treated animals, urine output was higher, metabolic acidosis was attenuated, and renal tubular architecture was protected. Coagulopathy was attenuated, and plasma interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-1 levels were significantly lower in the treated animals. These results show that blockade of coagulation attenuates acute lung and renal injury in established Gram-negative sepsis accompanied by antiinflammatory effects of therapy.Keywords
This publication has 32 references indexed in Scilit:
- Binding of Factor VIIa to Tissue Factor on Keratinocytes Induces Gene ExpressionPublished by Elsevier ,2000
- Low levels of tissue factor are compatible with development and hemostasis in mice.Journal of Clinical Investigation, 1998
- Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.Journal of Clinical Investigation, 1997
- Association of tissue factor with a γ chain homodimer of the IgE receptor type I in cultured human monocytesEuropean Journal of Immunology, 1996
- The Seven-transmembrane-spanning Receptors for Endothelin and Thrombin Cause Proliferation of Airway Smooth Muscle Cells and Activation of the Extracellular Regulated Kinase and c-Jun NH2-terminal Kinase Groups of Mitogen-activated Protein KinasesPublished by Elsevier ,1996
- Endothelin 1 and Thrombin Synergistically Stimulate IL-6 mRNA Expression and Protein Production in Human Umbilical Vein Endothelial CellsJournal of Cardiovascular Pharmacology, 1995
- The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor.Journal of Clinical Investigation, 1993
- Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.Journal of Clinical Investigation, 1993
- Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.Journal of Clinical Investigation, 1989
- Adult Respiratory-Distress SyndromeNew England Journal of Medicine, 1982